- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT06230614
Virkning af fortyndervolumen på Colistin-inhalationsterapi
Virkning af fortyndervolumen på Colistin-inhalationsterapi til mekanisk ventilerede respiratoriske patienter
The aim of this study is to investigate the impact of different diluent volumes for the same dosage of colistin in mechanically ventilated respiratory patients receiving colistin inhalation therapy. The study aims to determine whether the diluent volume has an effect on clinical outcomes, including ICU length of stay, total hospitalization duration, duration of respiratory support within 28 days, mortality rates within 28 days and 90 days, as well as analyze the pharmacokinetic profile of colistin in blood and bronchoalveolar lavage fluid. Additionally, the study will evaluate the incidence of nebulizer malfunctions and blockages. The findings of this research will help identify the optimal diluent volume for colistin inhalation therapy in clinical practice.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Background: Colistin is an antibiotic used to treat infections caused by multidrug-resistant Gram-negative bacteria. In recent years, it has been widely utilized as an inhaled antibiotic for the treatment of respiratory infections in critically ill patients on mechanical ventilation. Despite the increasing use of colistin inhalation therapy for ventilator-associated pneumonia, the clinical impact of diluent volume on nebulization efficiency remains unclear.
Study Design: A single-center, prospective, randomized controlled trial.
Methods: The study plans to enroll 60 participants. Colistin inhalation therapy will be administered using a blocked stratified random allocation. The control group will receive colistin 6 MU diluted in 6 ml of normal saline (1 MU per 1 ml), while the experimental group will receive colistin 6 MU diluted in 12 ml of normal saline (1 MU per 2 ml). The dosage, frequency, and administration method of colistin inhalation will follow the clinical standard of 6 MU, administered every 8 hours, continuously for 7 days.
Effect: The investigators anticipate that the clinical outcomes and pharmacokinetics of colistin inhalation therapy will not differ significantly between different diluent volumes. Based on comprehensive evaluation, a diluent volume of 12 ml is considered more suitable than 6 ml for the dilution of colistin.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Ke-Yun Chao, PhD
- Telefonnummer: +886-905-301-879
- E-mail: C00152@mail.fjuh.fju.edu.tw
Studiesteder
-
-
-
New Taipei City, Taiwan, 24352
- Rekruttering
- Fu Jen Catholic University Hospital, Fu Jen Catholic University
-
Kontakt:
- Ke-Yun Chao, PhD
- Telefonnummer: +886-905-301-879
- E-mail: ck_qq@hotmail.com
-
Ledende efterforsker:
- Ke-Yun Chao, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Admitted to the Intensive Care Unit.
- Age greater than 18 years and using a ventilator due to acute respiratory failure.
- Requires inhalation colistin treatment as determined by the disease.
- Sign the written informed consent form.
Exclusion Criteria:
- Renal failure requiring renal dialysis.
- Receiving both inhaled colistin and intravenous colistin treatments.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Aktiv komparator: Colistin 1 MU in normal saline 1 ml
1 MU of colistin in a total volume of 6 ml, diluted with a 1:1 ratio in normal saline (0.9%) |
Colistin 1 MU diluted in normal saline 1 ml, total volume of 12 ml |
|
Eksperimentel: Colistin 1 MU in normal saline 2 ml
1 MU of colistin in a total volume of 12 ml, diluted with a 1:2 ratio in normal saline (0.9%) |
Colistin 1 MU diluted in normal saline 2 ml, total volume of 12 ml |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Drug concentration
Tidsramme: One hour post inhalation therapy with colistin on the third day of treatment
|
Drug concentration in bronchoalveolar lavage fluid and blood |
One hour post inhalation therapy with colistin on the third day of treatment
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Ke-Yun Chao, PhD, Fu Jen Catholic University Hospital
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- FJUH112294
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .